BROWNSTEIN HYATT FARBER SCHRECK, LLP for ABBVIE
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report (this page) | Jan 18, 2023 | $60,000 | Replaced |
| 4th Quarter - Amendment | Jan 18, 2023 | $60,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to patient access, Issues related to pharmaceutical manufacturing, Issues related to treatment of endometriosis, Patent reform H.R.5801 - HELP Copays Act H.R.5376 Inflation Reduction Act of 2022
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURA JOHNSON BOLLIER | — |
| NADEAM ELSHAMI | — |
| EMILY FELDER | — |
| MARC LAMPKIN | — |
| ELIZABETH ANNE MAIER | — |
| ALFRED MOTTUR | — |
| ZACHARY PFISTER | — |
| ADAM STEINMETZ | — |
| HEATHER WADYKA | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.